Finance

Lists
AVG:ETR
Avantor Inc
€14.14
-0.07%
(-0.010) 1D
Nov 16, 1:17:42 PM GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for AVG...
Open
€14.14
High
€14.14
Low
€14.14
Mkt. cap
10.53B
Avg. vol.
32.00
Volume
0.00
52-wk high
€15.62
52-wk low
€8.20
No. of employees
14K
Open
€14.14
High
€14.14
Low
€14.14
Mkt. cap
10.53B
Avg. vol.
32.00
Volume
0.00
52-wk high
€15.62
52-wk low
€8.20
No. of employees
14K
News stories
From web sources and news partners
Profile
Avantor, Inc. is an American biotechnology, chemicals, and pharmaceutical company headquartered in Radnor, Pennsylvania. Established in 1904 as J.T. Baker, the company changed its name to Avantor in 2010. Avantor went public in 2019 and is now listed on the New York Stock Exchange under the symbol “AVTR”. Wikipedia
About Avantor Inc
CEO-
Employees13.5K
Founded1904
HeadquartersRadnor Township, Pennsylvania, United States
SectorHealth Care
Industry-
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
1.66B
1.58B
1.69B
1.70B
Cost of goods sold
1.14B
1.08B
1.16B
1.16B
Cost of revenue
1.14B
1.08B
1.16B
1.16B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
354.70M
401.70M
415.80M
395.80M
Operating expense
354.70M
401.70M
415.80M
395.80M
Total operating expenses
1.49B
1.48B
1.57B
1.56B
Operating income
169.20M
99.00M
121.20M
139.00M
Other non operating income
-7.00M
-
100.00K
-
EBT including unusual items
80.80M
55.50M
81.20M
98.00M
EBT excluding unusual items
120.10M
56.10M
81.80M
98.80M
Income tax expense
28.40M
12.20M
43.10M
-105.40M
Effective tax rate
35.15%
21.98%
53.08%
-107.55%
Other operating expenses
-
-
-
-
Net income
52.40M
43.30M
38.10M
203.40M
Net profit margin
3.15%
2.74%
2.25%
11.98%
Earnings per share
0.22
0.17
0.21
0.22
Interest and investment income
11.40M
10.50M
10.30M
10.20M
Interest expense
-53.40M
-53.40M
-49.70M
-51.80M
Net interest expenses
-42.00M
-42.90M
-39.40M
-41.60M
Depreciation and amortization charges
-
-
-
-
EBITDA
272.50M
204.00M
226.80M
244.30M
Gain or loss from assets sale
5.10M
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps